Trinity Biotech annual net debt
2015
2016
2017
2018
2019
2020
2022
2023
2024
2025
Trinity Biotech Net Debt Growth & History (TRIB)
Trinity Biotech's net debt was $132.8M for fiscal 2025.
View full Trinity Biotech company overviewTrinity Biotech annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $132.8M | $137.8M | — |
| 2024 | 2024-12-31 | −$5.0M | −$14.3M | — |
| 2023 | 2023-12-31 | $9.3M | $15.7M | — |
| 2022 | 2022-12-31 | −$6.4M | — | — |
| 2020 | 2020-12-31 | −$26.3M | −$12.1M | — |
| 2019 | 2019-12-31 | −$14.2M | −$83.8M | — |
| 2018 | 2018-12-31 | $69.6M | $126.2M | — |
| 2017 | 2017-12-31 | −$56.6M | $19.5M | — |
| 2016 | 2016-12-31 | −$76.1M | $25.9M | — |
| 2015 | 2015-12-31 | −$102.0M | — | — |
Trinity Biotech quarterly net debt
Q4.17
Q4.18
Q4.19
Q4.20
Q2.22
Q4.22
Q4.23
Q2.24
Q4.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $132.8M | $137.8M | — |
| Q2 2025 | 2025-06-30 | $111.0M | $103.8M | +1432.28% |
| Q4 2024 | 2024-12-31 | −$5.0M | −$14.3M | — |
| Q2 2024 | 2024-06-30 | $7.2M | — | — |
| Q4 2023 | 2023-12-31 | $9.3M | $15.7M | — |
| Q4 2022 | 2022-12-31 | −$6.4M | — | — |
| Q2 2022 | 2022-06-30 | $4.3M | — | — |
| Q4 2020 | 2020-12-31 | −$26.3M | −$12.1M | — |
| Q4 2019 | 2019-12-31 | −$14.2M | −$83.8M | — |
| Q4 2018 | 2018-12-31 | $69.6M | $126.2M | — |
| Q4 2017 | 2017-12-31 | −$56.6M | — | — |
Trinity Biotech net debt trends
Over the last five fiscal years, Trinity Biotech's net debt increased from −$26.3M to $132.8M, a change of $159.1M. The latest reported quarter, Q4 2025, shows $132.8M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Trinity Biotech source filings ↗